1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment
  6. Rivaroxaban (Xarelto)

Rivaroxaban (Xarelto)

46 - 60 of 105 Results
Sort Results:
Guideline: AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease (2017) August 2017
Article: Double-Check Dosing of Direct Oral Anticoagulants (DOACs) in Certain Patients July 2017
PL Voices: Anticoagulation for Venous Thromboembolism June 2017
Article: Investigate Low Doses of Direct Oral Anticoagulants June 2017
Article: Anticoagulation After an Intracranial Hemorrhage May Be Worth It in Atrial Fib May 2017
PL Voices: Antithrombotic Therapy in Patients with Atrial Fib and a Coronary Stent April 2017
Article: Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets April 2017
Chart: Anticoagulants in Pregnancy December 2016
PL Voices: Anticoagulation in Atrial Fibrillation October 2016
Article: Watch for UNDERdosing of Anticoagulants October 2016
PL Voices: Managing Interactions With Direct Oral Anticoagulants (DOACs) May 2016
Article: Be Cautious Reducing DOAC Doses Per Package Labeling May 2016
Article: Weigh the Risks and Benefits of DOACs for Venous Thromboembolism March 2016
PL Voices: Restarting Anticoagulation in Atrial Fibrillation After a GI Bleed February 2016
Article: Don't Delay Restarting Anticoagulation in Atrial Fib Patients After GI Bleeding February 2016